Pfizer Inc.

COVID-19 updates: Ontario, B.C., Manitoba announce new restrictions amid threat of Omicron variant

What you need to know about COVID-19 right now

Pfizer COVID-19 vaccine doses provide good protection against severe illness from Omicron variant, data show

Pfizer says final analysis of its COVID-19 pill shows near 90% efficacy in preventing hospitalizations, deaths

Pfizer to buy Arena Pharmaceuticals for $6.7-billion in all-cash deal

Early BioNTech, Pfizer data suggest boosters may protect against infection from Omicron variant

The close: TSX pares this week’s rally as investors mull seasonal support

Pfizer COVID-19 vaccine may only partially protect against Omicron, study says

Seven vaccine makers’ COVID-19 boosters raise immune response, British study says

EU regulator approves first COVID-19 vaccination for 5-11 year olds

Theranos founder Elizabeth Holmes denies trying to mislead on Pfizer partnership

Are the new COVID-19 pills a pandemic game-changer?

Canada receives first batch of COVID-19 pediatric vaccines

Evening Update: Health Canada approves first COVID-19 vaccine for kids aged 5 to 11

FDA authorizes Pfizer/BioNTech, Moderna COVID-19 boosters

COVID-19 vaccines for kids aged 5-11 roll out in Canada. What to know about efficacy, side effects and more

Health Canada approval of Pfizer’s COVID-19 vaccine for 5-11 year olds expected Friday, sources say

Pfizer, U.S. ink US$5.29-billion deal over possible COVID-19 treatment

Market movers: Stocks that saw action on Tuesday - and why